Chronic obstructive pulmonary disease, metabolic syndrome and diabetes mellitus

Česká verzia

Authors: Eva Rozborilová
Authors place of work: Klinika pneumológie a ftizeológie Jesseniovej LF UK a UNM, Martin
Published in the journal: Forum Diab 2016; 5(3): 142-145
Category: Topic

Summary

The increasing prevalence of chronic obstructive pulmonary disease is becoming worldwide problem. It represents a serious problem because of morbidity, mortality and treatment costs. COPD is multi-component disease associated with several extrapulmonary manifestations with create conditions for development of comorbidities.

Key words:
chronic obstructive pulmonary – disease comorbidity – metabolic syndrome – diabetes mellitus

Zdroje

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Update 2014. Dostupné z WWW: <http://www.goldcopd.org>.

2. Fletcher C, Peto R. The natural of chronic airflow obstruction. Br Med J 1977; 1(6077): 1645–1648.

3. Drugdová M, Krištúfek Peter, Majer Ivan et al. Chronická obštrukčná choroba pľúc: národné smernice pre prevenciu a terapiu. Slovenská pneumologická a ftizeologická spoločnosť: Bratislava 2011. ISBN 978–80–88866–98–5.

4. GOLD 2011. National Heart, Lung and Blood Institute and World Health Organization. Global initiative for chronic obstructive lund disease: Global strategy for diagnosis, management and prevention of chronic obstructive pulmonary disease. Dostupné z WWW: .

5. Vondra V, Malý M. Chronická komorbidita u chronické obstrukční plícní nemoci. Stud Pneumol Phthiseol 2008; 68(5): 199–207.

6. Baty F, Putora PM, Isenring B et al. Comorbidities and burden of COPD: a population based case-control study. PLoS ONE 2013; 8(5): e63285. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0063285>.

7. Skyba P, Ukropec J, Pobeha P et al. Metabolic Phenotype and Adipose Tissue Inflammation in Patients with Chronic Obstructive Pulmonary Disease. Mediators Inflamm 2010; 2010: 173498. Dostupné z DOI: <http://dx.doi.org/10.1155/2010/173498>.

8. Fabbry LM, Luppi F, Beghé B et al. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31(1): 204–212. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00114307>.

9. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33(5): 1165–1185. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.0012800>.

10. García-Olmos L, Alberquilla A, Ayala V et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study. BMC Fam Pract 2013; 14:11. Dostupné z DOI: <http://dx.doi.org/10.1186/1471–2296–14–11>.

11. Galajda P. Metabolický syndróm, kardiovaskulárne a metabolické riziká. Via Practica 2007; 4(Suppl 4): 5–9.

12. Bolton CE, Evans M, Ionescu AA et al. Insulin resistance and inflammation – A further systemic complication of COPD. COPD 2007; 4(2): 121–126.

13. Watz H, Waschki B, Kirsten A et al. The Metabolic Syndrome in Patients with Chronic Bronchitis and COPD Fragnency and Associated Cousegnences for Systemic Inflammation and Physical Inactivity. Chest 2009; 136(4): 1039–1046. Dostupné z DOI: <http://dx.doi.org/10.1378/chest.09–0393>.

14. Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013; 1(1): 73–83. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213–2600(12)70060–7>.

15. Mokáň M, Martinka E, Galajda P. Diabetes mellitus a vybrané metabolické ochorenia. P+M: Turany 2008. ISBN 178–80–969713–9-8.

16. Mannino DM, Thorn D, Swensen A et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32(4): 962–969. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00012408>.

17. Benčová A, Antošová M, Kocan I et al. Komorbidity a chronická obštrukčná choroba pľúc. Stud Pneumol Phthiseol 2014;74(2): 65–73.